Gautry P, Bussereau M
Sem Hop. 1984 Jan 12;60(1):63-5.
The results of a clinical trial of a new presentation designed for pediatric patients in 29 children are reported. Rectal temperature was recorded every 3 hours, for 12 hours. Patients were given a 12 mg/kg dose every 6 hours. A significant and satisfactory decrease in body temperature was observed. No undesirable side effects were recorded.
报告了一项针对儿科患者设计的新剂型在29名儿童中的临床试验结果。每3小时记录一次直肠温度,持续12小时。患者每6小时服用12毫克/千克的剂量。观察到体温有显著且令人满意的下降。未记录到不良副作用。